Sanofi (SNYNF) EBT Margin Growth (5y) (2014 - 2026)
Sanofi (SNYNF) EBT Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Gsk |
94,972,132.98 Bn |
94,972,128.02 Bn |
7.76 Bn |
| 2 |
Eli Lilly |
1,006.91 Bn |
1,001.63 Bn |
16.22 Bn |
| 3 |
Johnson & Johnson |
565.25 Bn |
543.20 Bn |
15.96 Bn |
| 4 |
AbbVie |
392.62 Bn |
383.27 Bn |
10.78 Bn |
| 5 |
Merck |
285.22 Bn |
279.57 Bn |
12.09 Bn |
| 6 |
Amgen |
188.94 Bn |
176.90 Bn |
5.87 Bn |
| 7 |
Gilead Sciences |
154.59 Bn |
146.86 Bn |
5.52 Bn |
| 8 |
Pfizer |
147.99 Bn |
135.22 Bn |
-1.21 Bn |
| 9 |
Bristol Myers Squibb |
114.76 Bn |
104.31 Bn |
8.07 Bn |
| 10 |
Sanofi |
- |
- |
9.49 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
-321.00 |
| Dec 31, 2025 |
5,056.00 |
| Sep 30, 2025 |
-293.00 |
| Jun 30, 2025 |
-8,322.00 |
| Mar 31, 2025 |
135.00 |
| Dec 31, 2024 |
2,562.00 |
| Sep 30, 2024 |
762.00 |
| Jun 30, 2024 |
2,166.00 |
| Mar 31, 2024 |
-145.00 |
| Dec 31, 2023 |
1,655.00 |
| Sep 30, 2023 |
-78.00 |
| Jun 30, 2023 |
762.00 |
| Mar 31, 2023 |
933.00 |
| Dec 31, 2022 |
2,892.00 |
| Sep 30, 2022 |
-31.00 |
| Jun 30, 2022 |
-197.00 |
| Mar 31, 2022 |
474.00 |
| Dec 31, 2021 |
-2,242.00 |
| Sep 30, 2021 |
52.00 |
| Jun 30, 2021 |
148.00 |
